Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Toxicon ; 46(8): 921-6, 2005 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-16263148

RESUMEN

Acute pancreatitis (AP) is an inflammatory disease of the pancreas characterized by local inflammation and extrapancreatic effects such as lung injury. Secretory phospholipases A(2) (PLA(2)s) have been implicated in triggering AP, but their exact role to evoke AP is largely unknown. Therefore, we have tested the ability of sPLA(2)s to induce AP in rats, using venom sPLA(2)s with residual or high enzymatic activity (bothropstoxin-II and Naja mocambique mocambique venom PLA(2), respectively), as well as sPLA(2) devoid of catalytic activity (piratoxin-I). The injection of Naja m. mocambique venom PLA(2), bothropstoxin-II or piratoxin-I (300 microg/kg each) into the common bile duct increased significantly the pancreatic plasma extravasation and myeloperoxidase activity. The lung myeloperoxidase and serum amylase were also increased for all groups, although the Naja mocambique mocambique venom PLA(2) induced higher lung myeloperoxidase and serum amylase values, compared with piratoxin-I and/or bothropstoxin-II. Histopathology of pancreas and lungs in piratoxin-I-injected rats showed interstitial oedema in both tissues, and neutrophil infiltration with acinar cell necrosis in pancreas. In conclusion, sPLA(2)s induce AP in rats and the catalytic activity is not essential to induce the local effects in pancreas, although it appears to contribute partly to the remote lung injury.


Asunto(s)
Venenos Elapídicos/química , Pulmón/patología , Páncreas/patología , Pancreatitis Aguda Necrotizante/inducido químicamente , Fosfolipasas A/toxicidad , Amilasas/sangre , Análisis de Varianza , Animales , Venenos de Crotálidos , Venenos Elapídicos/toxicidad , Fosfolipasas A2 Grupo II , Pulmón/efectos de los fármacos , Páncreas/efectos de los fármacos , Peroxidasa/metabolismo , Fosfolipasas A/química , Ratas , Proteínas de Reptiles
2.
Toxicon ; 41(7): 823-9, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12782082

RESUMEN

The ability of the phospholipases A(2) (PLA(2)s) from Crotalus durissus cascavella, Crotalus durissus collilineatus and Crotalus durissus terrificus venoms and crotapotin to increase the vascular permeability in the rat skin as well as the contribution of both mast cells and sensory C-fibers have been investigated in this study. Vascular permeability was measured as the plasma extravascular accumulation at skin sites of intravenously injected 125I-human serum albumin. Intradermal injection of crotalic PLA(2)s (0.05-0.5 microg/site) in the rat skin resulted in dose-dependent increase in plasma extravascular whereas crotapotin (1 microg/site) failed to affect this response. Co-injection of crotapotin (1 microg/site) did not modify the increased vascular permeability induced by the PLA(2)s (0.05-0.5 microg/site). Previous treatment (30 min) of the animals with cyproheptadine (2 mg/kg, i.p.) markedly reduced PLA(2) (0.5 microg/site)-induced oedema. In rats treated neonatally with capsaicin to deplete neuropeptides, the plasma extravasation induced by all PLA(2)s (0.5 microg/site) was also significantly reduced. Similarly, the tachykinin NK(1) receptor antagonist SR140333 (1nmol/site) significantly reduced the PLA(2)-induced oedema. In addition, the combination of SR140333 with cyproheptadine further reduced the increased plasma extravasation by PLA(2) from C. d. cascavella venom, but not by PLA(2) from C. d. terrificus and C. d. collilineatus venoms. Our results suggest that increase in skin vascular permeability by crotalic PLA(2)s is mediated by activation of sensory C-fibers culminating in the release of substance P, as well as by activation of mast cells which in turn release amines such as histamine and serotonin.


Asunto(s)
Venenos de Crotálidos/toxicidad , Edema/inducido químicamente , Mastocitos/efectos de los fármacos , Fibras Nerviosas Amielínicas/efectos de los fármacos , Fosfolipasas A/toxicidad , Piel/efectos de los fármacos , Animales , Permeabilidad Capilar/efectos de los fármacos , Venenos de Crotálidos/administración & dosificación , Crotalus , Crotoxina/administración & dosificación , Crotoxina/toxicidad , Relación Dosis-Respuesta a Droga , Inyecciones Intradérmicas , Masculino , Fosfolipasas A/administración & dosificación , Ratas , Ratas Wistar
3.
Neurosci Lett ; 318(3): 158-62, 2002 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-11803123

RESUMEN

The leukocyte migration induced by Phoneutria nigriventer spider venom (PNV) has been investigated in rats using the pleurisy model. Intrapleural injection of PNV (10-100 microg/cavity) caused a dose- and time-dependent leukocyte accumulation. The bradykinin B(2) receptor antagonist Hoe 140 (0.5 mg/kg) substantially inhibited PNV-induced cell accumulation, whereas the angiotensin-converting enzyme inhibitor captopril (2 mg/kg) potentiated by 80% this effect. The non-specific kallikrein inhibitor aprotinin and the plasma kallikrein inhibitor soybean trypsin inhibitor greatly reduced PNV-induced leukocyte migration, whereas the selective tissue kallikrein inhibitor P(ac)-F-S-R-EDDnp failed to affect PNV-induced responses. Treatment of rats with capsaicin (50 mg/kg) at the neonatal stage resulted in 67% inhibition of the PNV-induced cell migration. The neurokinin NK(1) receptor antagonist SR140333, but not the NK(2) receptor antagonist SR48968, reduced by 55% venom-induced cell accumulation. We conclude that bradykinin generation is involved in the PNV-induced pleural leukocyte migration in rats, where it can directly activate sensory nerves contributing to a neurogenic inflammatory mechanism.


Asunto(s)
Bradiquinina/metabolismo , Quimiotaxis de Leucocito/efectos de los fármacos , Inflamación Neurogénica/inducido químicamente , Neuronas Aferentes/efectos de los fármacos , Pleura/inervación , Pleuresia/inducido químicamente , Venenos de Araña/toxicidad , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Aprotinina/farmacología , Benzamidas/farmacología , Bradiquinina/farmacología , Antagonistas de los Receptores de Bradiquinina , Capsaicina/farmacología , Quimiotaxis de Leucocito/fisiología , Relación Dosis-Respuesta a Droga , Leucocitos/efectos de los fármacos , Leucocitos/inmunología , Leucocitos/metabolismo , Masculino , Inflamación Neurogénica/metabolismo , Inflamación Neurogénica/fisiopatología , Antagonistas del Receptor de Neuroquinina-1 , Neuronas Aferentes/metabolismo , Piperidinas/farmacología , Pleura/efectos de los fármacos , Pleura/fisiopatología , Pleuresia/metabolismo , Pleuresia/fisiopatología , Quinuclidinas/farmacología , Ratas , Ratas Wistar , Receptores de Bradiquinina/metabolismo , Receptores de Neuroquinina-1/metabolismo , Proteínas de Soja/farmacología , Inhibidores de Tripsina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA